Enveric Biosciences, Inc. (NASDAQ: ENVB) reported Q2 EPS of ($0.23), $0.24 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Enveric Biosciences, Inc. (ENVB) click here.